Upstream Bio (UPB)

Profile

Full Name

Upstream Bio, Inc.

Ticker Symbol

UPB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://upstreambio.com

Employees

52

Key Details

Price

$8.58(+4.51%)

Market cap

$460.24M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.37M(-0.42% YoY)

Annual EPS

-$5.58(-429.81% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$8.58
UPB price is $8.58

30-Day Relative Volume

0.77
UPB 30-day relative volume is 0.77

Price Performance

Price Most recent change

+4.51%
UPB price was up +4.51% on May 7, 2025

Price YTD change

-47.81%
UPB price is down -47.81% since January 1st

Price 1-year change

-
UPB price 1-year change is unknown

Price 3-year change

-
UPB price 3-year change is unknown

Price Range

Price All-time high

$29.46
UPB price is currently -70.88% below its historical high of $29.46

Price 3-year low

$5.14
UPB price is currently +66.93% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$460.24M
UPB market capitalization is $460.24 million

Market cap 3-year change

-
UPB market capitalization 3-year change is unknown

Market cap All-time high

$1.47B
UPB market capitalization is currently -68.65% below its historical high of $1.47 billion

Market cap sector rank

67.7%
UPB market capitalization is higher than 67.7% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
UPB shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
UPB shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.01
UPB beta is 1.01

200-day SMA

$14.30
UPB price is currently -39.99% below its 200-day simple moving average

50-day SMA

$8.04
UPB price is currently +6.72% above its 50-day simple moving average

RSI

52.15
UPB 14-day relative strength index is 52.15

Volume

0.77
UPB 30-day relative volume is 0.77

ATR

$0.90
UPB average true range is $0.90

10-day Historical Volatility

65.51%
UPB 10-day historical volatility is 65.51%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.37M
UPB annual revenue is $2.37 million

Revenue Analysts estimate

$1.50M
UPB annual revenue is currently +57.82% higher than the consensus analysts' forecast

Revenue 1-year change

-0.42%
UPB annual revenue is down -0.42% year-on-year

Revenue Sector rank

15.8%
UPB annual revenue is higher than 15.8% of companies in Healthcare sector

EPS

EPS

-$5.58
UPB annual earnings per share is -$5.58

EPS Analysts estimate

-$2.40
UPB annual earnings per share is currently +132.53% higher than the consensus analysts' forecast

EPS 1-year change

-429.81%
UPB annual earnings per share is down -429.81% year-on-year

EPS Sector rank

17.68%
UPB annual earnings per share is higher than 17.68% of companies in Healthcare sector

Profit

Gross profit

-
UPB annual gross profit value is unknown

Gross margin

-
UPB annual gross profit margin value is unknown

Operating profit

-$77.76M
UPB annual operating income is -$77.76 million

Operating margin

-3281.18%
UPB annual operating profit margin is -3281.18%

Net income

-$62.81M
UPB annual net profit is -$62.81 million

Net margin

-2650.04%
UPB annual net profit margin is -2650.04%

Expenses

Total expenses

$80.13M
UPB annual total expenses is $80.13 million

Operating expenses

$80.13M
UPB annual total operating expenses is $80.13 million

Cost of goods sold

-
UPB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$17.17M
UPB annual SGA is $17.17 million

Depreciation and amortization

$89.00K
UPB annual depreciation & amortization is $89.00 thousand

Interest expense

-
UPB annual interest expense value is unknown

Income tax

-
UPB annual income tax value is unknown

EBIT & EBITDA

EBIT

-$77.76M
UPB annual earnings before interest & taxes is -$77.76 million

EBITDA

-$77.67M
UPB annual EBITDA is -$77.67 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$481.72M
UPB annual total assets is $481.72 million

Non current assets

$2.56M
UPB annual long term assets is $2.56 million

Current assets

$479.16M
UPB annual total current assets is $479.16 million

Cash and cash equivalents

$325.89M
UPB annual cash & cash equivalents is $325.89 million

Accounts receivable

$613.00K
UPB annual accounts receivable is $613.00 thousand

Inventory

-
UPB annual inventory value is unknown

Liabilities

Total liabilities

$11.87M
UPB annual total liabilities is $11.87 million

Long term liabilities

$1.13M
UPB annual total long term liabilities is $1.13 million

Current liabilities

$10.74M
UPB annual total current liabilities is $10.74 million

Accounts payable

$4.04M
UPB annual accounts payable is $4.04 million

Debt

Total debt

$1.83M
UPB annual total debt is $1.83 million

Total debt 1-year change

+3975.56%
UPB annual total debt is up +3975.56% year-on-year

Long term debt

$1.13M
UPB annual long term debt is $1.13 million

Short term debt

$704.00K
UPB annual short term debt is $704.00 thousand

Equity & Capital

Shareholders equity

$469.85M
UPB annual stockholders equity is $469.85 million

Book value

$469.85M
UPB annual book value is $469.85 million

Retained earnings

-$190.78M
UPB annual retained earnings is -$190.78 million

Working capital

$468.42M
UPB annual working capital is $468.42 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$59.17M
UPB annual cash flow from operations is -$59.17 million

Cash from operations 1-year change

-56.02%
UPB annual cash flow from operations is down -56.02% year-on-year

Cash from investing

-$59.48M
UPB annual cash flow from investing activities is -$59.48 million

Cash from investing 1-year change

+28.19%
UPB annual cash flow from investing activities is up +28.19% year-on-year

Cash from financing

$418.91M
UPB annual cash flow from financing activities is $418.91 million

Cash from financing 1-year change

+223.36%
UPB annual cash flow from financing activities is up +223.36% year-on-year

CAPEX

CAPEX

$511.00K
UPB annual capital expenditures is $511.00 thousand

CAPEX 1-year change

+254.86%
UPB annual capital expenditures is up +254.86% year-on-year

Free Cash Flow

Free cash flow

-$59.68M
UPB annual free cash flow is -$59.68 million

Free cash flow 1-year change

-56.77%
UPB annual free cash flow is down -56.77% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
UPB annual gross profit margin value is unknown

Operating margin

-3281.18%
UPB annual operating profit margin is -3281.18%

Net margin

-2650.04%
UPB annual net profit margin is -2650.04%

ROA & ROE

ROA

-20.97%
UPB annual return on assets is -20.97%

ROE

-36.23%
UPB annual return on equity is -36.23%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
UPB price to earnings ratio value is unknown

PE ratio Sector rank

-
UPB price to earnings ratio is unknown

PB Ratio

PB ratio

0.98
UPB price to book ratio is 0.98

PB ratio Sector rank

43.73%
UPB price to book ratio is higher than 43.73% of companies in Healthcare sector

PS Ratio

PS ratio

377.25
UPB price to sales ratio is 377.25

PS ratio Sector rank

97.03%
UPB price to sales ratio is higher than 97.03% of companies in Healthcare sector

Enterprise value

Enterprise value

$136.18M
UPB enterprise value is $136.18 million

Enterprise value Sector rank

52.47%
UPB enterprise value is higher than 52.47% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.02
UPB EV/EBITDA is -3.02

EV/EBITDA Sector rank

27.21%
UPB EV/EBITDA is higher than 27.21% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

44.63
UPB annual current ratio is 44.63

Quick ratio

-
UPB annual quick ratio value is unknown

Leverage

Debt to equity

0.00
UPB annual debt to equity ratio is 0.00

Interest coverage ratio

-
UPB annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
UPB piotroski f-score value is unknown

Altman Z-Score

23.35
UPB altman z-score is 23.35

Analyst ratings

Recent major analysts updates

Nov 5, 24 William Blair
Outperform
Nov 5, 24 TD Cowen
Buy
Nov 5, 24 Piper Sandler
Overweight
Nov 5, 24 JP Morgan
Overweight

Institutional Ownership

Similar stocks

CYH logo
Community Health Systems (CYH)
ETON logo
Eton Pharmaceuticals (ETON)
SVA logo
Sinovac Biotech (SVA)
MDRX logo
Veradigm (MDRX)
CCRN logo
Cross Country Healthcare (CCRN)
URGN logo
UroGen Pharma (URGN)
SNDA logo
Sonida Senior Living (SNDA)
STOK logo
Stoke Therapeutics (STOK)
OFIX logo
Orthofix Medical (OFIX)
  • What is the ticker symbol for Upstream Bio?
  • Does Upstream Bio pay dividends?
  • What sector is Upstream Bio in?
  • What industry is Upstream Bio in?
  • What country is Upstream Bio based in?
  • Is Upstream Bio in the S&P 500?
  • Is Upstream Bio in the NASDAQ 100?
  • Is Upstream Bio in the Dow Jones?
  • When was Upstream Bio's last earnings report?
  • When does Upstream Bio report earnings?
  • Should I buy Upstream Bio stock now?

What is the ticker symbol for Upstream Bio?

The ticker symbol for Upstream Bio is NASDAQ:UPB

Does Upstream Bio pay dividends?

No, Upstream Bio does not pay dividends

What sector is Upstream Bio in?

Upstream Bio is in the Healthcare sector

What industry is Upstream Bio in?

Upstream Bio is in the Biotechnology industry

What country is Upstream Bio based in?

Upstream Bio is headquartered in United States

Is Upstream Bio in the S&P 500?

No, Upstream Bio is not included in the S&P 500 index

Is Upstream Bio in the NASDAQ 100?

No, Upstream Bio is not included in the NASDAQ 100 index

Is Upstream Bio in the Dow Jones?

No, Upstream Bio is not included in the Dow Jones index

When was Upstream Bio's last earnings report?

Upstream Bio's most recent earnings report was on Mar 12, 2025

When does Upstream Bio report earnings?

The next expected earnings date for Upstream Bio is May 30, 2025

Should I buy Upstream Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page